---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017539"
form_type: "8-K"
ticker: null
cik: "0000895665"
company_name: "Clearday, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:32:27.876604+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Clearday director Jeffrey Coleman resigns; plans to add director for Viveon merger

## Summary
- Jeffrey A. Coleman resigned as director on April 30, 2024, not due to any disagreement with the company.
- CEO James Walesa thanked Coleman for his service since the September 2021 merger.
- Company plans to add one more director to support the business combination with Viveon Healthcare Acquisition Corp (VHAQ).
- New director likely from technology or healthcare sector to support digital assistants line.

## SEC filing metadata
- accession: 0001493152-24-017539
- form_type: 8-K
- cik: 0000895665
- company_name: Clearday, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/895665/000149315224017539/0001493152-24-017539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/895665/000149315224017539/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017539
- JSON: https://secwatch.observer/filing/0001493152-24-017539.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017539.txt

## Key facts
- Executive change
  Jeffrey A. Coleman resigned as director at Clearday, Inc..
  - Action: resigned
  - Role: director
  source text: On April 30, 2024, Jeffrey A. Coleman tendered his resignation as a director of Clearday, Inc. (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/895665/000149315224017539/0001493152-24-017539-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.